Sunday, November 3, 2024
HomeTagsNotice From Nasdaq

Notice From Nasdaq

Stealth Biotherapeutics Announces Receipt of Non-compliance Notice From Nasdaq

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced that...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics